It will be very tight. But they obviously have some stout backers. I was surprised they got the recent CR away at the current price.Best to watch from the sidelines.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025